Effects of Neo40® Daily on Biomarkers of Cardiovascular Risks: A Clinical Trial
Dr. Nathan S. Bryan Description: Conducted at The Houston Institute for Clinical Research, blood analysis by LabCorp N=30, statistical analysis at 95% confidence level. Double-blinded, placebo controlled study of patients over 40 with 3 or more of the following cardiovascular risk factors: hypertension, obesity, hyperlipidemia, smoking, sedentary, family history of CVD and diabetes. Baseline blood draw, then 30-day regimen of Neo40 Daily followed by another blood draw. Objective: Measure effect of Neo40 Daily on biomarkers for cardiovascular risk & markers for nitric oxide production. Summary of patients taking Neo40 Daily: There was no significant change in placebo patients.
After 30 days of Neo40® Daily
Plasma nitrite levels doubled, indicating increased nitric oxide levels
Statistically significant reduction in triglycerides
7-35% reduction in c-reactive proteins in patients with elevated levels
Over half of patients reported feeling more energetic and less anxious
Calls To Study Health Benefits Of Nitrate, Nitrite.
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world.
Aging is associated with Endothelial Dysfunction.
Inorganic Nitrate Supplementation Lowers Blood Pressure in Humans.
Circulation Research – American Heart Association Journals